Insight 2811 Inc’s GSK GSK Stock Holding History

Insight 2811 Inc’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-45,362	Closed	-$3.03M	–	174
2014 Q2	$3.03M	Sell	45,362 -2,095	-4%	-$142K	1.27%	14
2014 Q1	$3.29M	Buy	+47,457	New	+$3.21M	1.39%	13

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Insight 2811 Inc's GSK Position: Q3 2014 in Review

Insight 2811 Inc sold out of GSK (GSK) in Q3 2014, closing a stake of 45,362 shares — an estimated $3.03M sold.

Insight 2811 Inc first reported a position in GSK in Q1 2014 and held it in 2 quarters. The position peaked at $3.29M in Q1 2014. 701 funds tracked by Wall St. Rank hold GSK as of Q3 2014.

Insight 2811 Inc reported no remaining GSK position as of Q3 2014 after selling out during the quarter.
Insight 2811 Inc sold 45,362 GSK shares in Q3 2014, an estimated $3.03M.
Insight 2811 Inc first reported a position in GSK in Q1 2014 and held it in 2 quarters.
Insight 2811 Inc's GSK position peaked at $3.29M in Q1 2014.
701 funds tracked by Wall St. Rank held GSK as of Q3 2014.

Based on Insight 2811 Inc's 13F filing for Q3 2014, filed 14 Nov 2014.